Drug intelligence / Profile preview

Kroc Skin

Development stage: Preclinical
Modality: Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration: Topical

Overview

Kroc Skin appears to refer to a topical antibacterial gel, likely intended for medical skin care. The only available reference is from a clinical trial registry in China, which lists "Kroc Skin antibacterial gel" as an investigational product for skin care. There is no evidence that "Kroc Skin" refers to the illicit opioid desomorphine (commonly known as krokodil), nor does it appear related to any pharmaceutical or controlled substance with systemic effects. The product seems distinct from the street drug "krokodil," and there are no details on its active ingredients, mechanism of action, or developer beyond its use as an antibacterial hydrogel[6].

Brand names: Kroc Skin
Other names: Kroc Skin antibacterial gel

Beyond the preview

Go deeper on Kroc Skin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kroc Skin.

Explore the full profile